4
Changes in Ownership
Lexeo Therapeutics, Inc. Filed Acc 0001415889-24-029143
Chief Executive Officer sold 2,500 shares at $8.20 ($20,491)
- Chief Executive Officer acquired 2,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Townsend Richard Nolan · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-12-10 | Exercise or conversion : show line 1 in the form 10b5-1 | +2,500 | $2.33 | $5,825 | 123,195 | D |
| 2024-12-10 | Sale : show line 2 in the form 10b5-1 | −2,500 | $8.20 | $20,491 | 120,695 | D |
| Open-market sales · 2,500 sh · avg $8.20 · $20,491 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-12-10 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (right to buy) | −2,500 | 118,655 | D |
Loading xslF345X05/form4-12122024_051206.xml…